Lets look at what we have here
Looks like a very experianced board of directors which over recent years has been rejuvinated to fit the space for this company's next phaze of growth which IMO BLT is on the cusp of.
Correct me if I'm wrong with this statement but just reading between the lines on the clinical results from the trial data on the web site, they appear to have products that could clearly reduce or even in some cases replace the need of certain antibiotic treatments
originally bought about 600,000 shares at .032 and to get my average down recently purchased another 400,000 at .016 so when its back at about 2.6 cents I'll be about square, but at the moment see this as a long term play and based on what this company has, should at some stage soon have plenty of good upside
Anyways still pretty quiet around here, guess thats enough mumblings to myself
